Previous close | 7.7200 |
Open | 0.1900 |
Bid | 0.0800 |
Ask | 0.1200 |
Strike | 62.50 |
Expiry date | 2024-05-17 |
Day's range | 0.1100 - 0.1900 |
Contract range | N/A |
Volume | |
Open interest | 80 |
Shares of CVS Health (CVS) are falling during Wednesday's trading session after the company revised its full-year guidance downward, citing mounting pressure from rising medical costs. The adjustment to the company's guidance comes on the heels of CVS's weaker-than-expected first quarter results, which missed estimates for both revenue and earnings. Yahoo Finance's Anjalee Khemlani breaks down the report. For more expert insight and the latest market action, click here to watch this full episode of Morning Brief. This post was written by Angel Smith
(Bloomberg) -- CVS Health Corp. shares tumbled the most in nine years after the company cut its annual earnings outlook for the second quarter in a row, citing increased medical costs in its Medicare insurance business.Most Read from BloombergTesla Axes Supercharger Team in Blow to Broader EV MarketNYC Police Break Up Columbia Protest and Clashes Erupt at UCLAFed to Signal Delay of Interest-Rate CutsLilly Soars as Forecast Boost Shows Weight-Loss Drugs’ PowerAmazon Posts Biggest Cloud Sales Grow
CVS cut its guidance for full-year earnings per share to at least $7, down from a prior forecast of $8.30.